TREATMENT PATTERNS AND HEALTHCARE RESOURCE UTILIZATION IN RUXOLITINIB-TREATED PATIENTS WITH MYELOFIBROSIS WITH AND WITHOUT ANEMIA: A REAL-WORLD ANALYSIS

被引：0
|
作者：
Liu, T. [1 ]
Fillbrunn, M. [2 ]
Chen, J. [2 ]
Sajeev, G. [2 ]
Zhang, S. [3 ]
Signorovitch, J. [2 ]
机构：
[1] GSK plc, Philadelphia, PA USA
[2] Anal Grp Inc, Boston, MA USA
[3] GSK, Philadelphia, PA USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE407
引用
收藏
页码：S132 / S132
页数：1
相关论文
共 50 条
  • [1] Treatment patterns and healthcare resource utilization in ruxolitinib-treated patients with myelofibrosis with and without anemia: a real-world analysis
    Liu, Tom
    Fillbrunn, Mirko
    Zhang, Shiyuan
    Chen, Jingyi
    Li, Weilong
    Platt, Julia
    Niehoff, Nicole
    Sajeev, Gautam
    Signorovitch, James
    ANNALS OF HEMATOLOGY, 2025, : 1605 - 1616
  • [2] Real-World Analysis of Ruxolitinib Treatment Patterns and Outcomes Among Patients with Myelofibrosis
    Burton, Tanya
    Parikh, Kejal
    Patel, Manish
    Sundquist, Kevin
    Lal, Lincy S.
    Copher, Ronda
    Gerds, Aaron T.
    BLOOD, 2019, 134
  • [3] Retrospective Real-World Analysis of Baseline Characteristics, Treatment Patterns, and Survival in Patients With Myelofibrosis and Anemia Receiving Ruxolitinib
    Kuykendall, Andrew T.
    Fillbrunn, Mirko
    Liu, Tom
    Zhang, Shiyuan
    Zhang, Adina
    Simpson, Ryan
    Sajeev, Gautam
    Signorovitch, James
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S438 - S439
  • [4] Second primary malignancies in ruxolitinib-treated myelofibrosis: real-world evidence from 219 consecutive patients
    Maffioli, Margherita
    Giorgino, Toni
    Mora, Barbara
    Iurlo, Alessandra
    Elli, Elena
    Finazzi, Maria Chiara
    Caramella, Marianna
    Rumi, Elisa
    Carraro, Maria Cristina
    Polverelli, Nicola
    D'Adda, Mariella
    Malato, Simona
    Rossi, Marianna
    Molteni, Alfredo
    Vismara, Alessandro
    Sissa, Cinzia
    Spina, Francesco
    Anghilieri, Michela
    Cattaneo, Daniele
    Renso, Rossella
    Bellini, Marta
    Pioltelli, Maria Luisa
    Cavalloni, Chiara
    Barraco, Daniela
    Accetta, Raffaella
    Bertu, Lorenza
    Della Porta, Matteo Giovanni
    Passamonti, Francesco
    BLOOD ADVANCES, 2019, 3 (21) : 3196 - 3200
  • [5] Real-World Use of Ruxolitinib in Patients with Myelofibrosis and Anemia or Thrombocytopenia at Diagnosis
    Yu, Jingbo
    Bland, Emily
    Schuler, Tammy
    Cordaro, Thomas
    Braunstein, Evan
    ACTA HAEMATOLOGICA, 2024,
  • [6] Real-World Resource Utilization Patterns of Patients Treated With Cholangioscopy
    Pleskow, D.
    Cangelosi, M. J.
    Faucher, S.
    Stockwell, B.
    Khamamkar, V.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S952 - S952
  • [7] Real-World Ruxolitinib Treatment Pattern in Myelofibrosis Patients With Thrombocytopenia
    Kabir, Sujan
    Mei, Jian
    Wang, Yifei
    Ichikawa, Natsumi
    Ino, Suichi
    Lebedinsky, Claudia
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S336 - S337
  • [8] Real-World Utilization of Fedratinib for Myelofibrosis Post-Ruxolitinib: Patient Characteristics, Treatment Patterns, and Characterization of Ruxolitinib Failure
    Harrison, Claire N.
    Mascarenhas, John
    Abraham, Pranav
    Kee, Arianna
    Nadal, Jose Alberto
    Balanean, Alexandrina
    McBride, Ali
    Kish, Jonathan K.
    Liassou, Djibril
    Feinberg, Bruce A.
    Gerds, Aaron T.
    BLOOD, 2021, 138
  • [9] Real-world treatment patterns and healthcare resource utilization among migraine patients: a German claims database analysis
    Gaul, Charly
    Seidel, Karolin
    Heuck, Alexander
    Silaidos, Carmina
    Mrosowsky, Thora
    Eberhardt, Alice
    Fritz, Bjorn
    Jacob, Christian
    JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 667 - 678
  • [10] Real-World Outcome of Patients with Myelofibrosis Treated with Ruxolitinib in the West of Scotland: A Retrospective Multicentre Analysis
    Dikair, Abdalla
    Hopkins, David
    Rafferty, Mark
    Louden, Gail
    Drummond, Mark
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 197 : 78 - 78
12345